Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

Dr Pavan Bhargava anticipates updates on diagnostic criteria, MRI techniques, biomarkers, treatments, and the role of diet in ...

It took a decade for Heather Castellani Milboer to be diagnosed with multiple sclerosis. Now, she helps build community for ...

Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

March is Multiple Sclerosis Awareness Month, and a local yoga instructor is hosting a free class this weekend.

Good food for a good cause is what was happening at the 4th annual Moboil. It was a chance to bring awareness to multiple ...

Sanofi (NASDAQ:SNY) said on Tuesday that the US FDA has granted priority review for the regulatory submission of tolebrutinib ...

The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...

Multiple sclerosis turned Hollie Amadio's life upside-down, but a chance encounter gave her a new purpose on behalf of the MS ...